We are saddened by the passing of former First Lady Barbara Bush and express our deepest condolences to the Bush Family.
New Study Seeks to Determine Effectiveness of Synthetic Cannabinoid in Relieving Joint Pain in Lupus
A new clinical trial is underway to test the efficacy efficacy of a synthetic cannabinoid derivative for joint pain.
Announcing a new white paper, "Lupus Community Panel Proposals for Optimizing Clinical Trials: 2018," developed to address critical issues that have stymied the lupus drug development process for decades.
The Omnibus Appropriations bill passed by the US House of Representatives on March 22 includes increased funding for critical lupus research and education programs.
Mallory held a Make Your Mark fundraiser during Lupus Awareness Month in 2017, now she’s looking forward to reaching a new fundraising goal in 2018.
The Lupus Foundation of America announces the election of two new board members, Andrew Brophy and Barbara Polk.
New datasets provide insight for cells in lupus and RA disease tissue.
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.